Stock Taper Revenue: $176.1 million, up 14% year-over-year.
Gross Profit: $49.9 million.
Operating Income: $10.4 million.
Net Income: $16.8 million; Adjusted Net Income: $38.7 million.
Earnings Per Share: $0.77 (diluted), $1.77 (adjusted).
Backlog: Increased to $4.5 billion, with $3.7 billion in the LEU segment and $0.8 billion in Technical Solutions.
Strong demand across major markets: commercial LEU, national security, and HALEU.
Secured a $900 million task order from the DOE to support large-scale production capacity.
Completed HALEU production requirements ahead of schedule, producing nearly 2 metric tons of HALEU UF6.
Signed agreements with Oklo and X-energy for HALEU supply, including prepayment structures to support funding.
Progress in workforce additions, with a target of over 175 new hires in Piketon, up from 100.
Centrus was added to the S&P SmallCap 600 Index, highlighting its role in U.S. energy security.
Reaffirmed 2026 revenue guidance of $450 million to $500 million.
Capital expenditures expected between $350 million and $500 million.
Anticipated completion of the first centrifuge at the Oak Ridge facility in 2026.
Continued focus on expanding the workforce and operational capabilities to meet growing demand.
Decline in net income compared to Q2 2025, attributed to increased SG&A and advanced technology costs.
SWU revenue decreased by 23% due to lower volumes, despite a 3% increase in average pricing.
Increased costs in uranium and SWU sales, with a significant rise in cost of sales impacting margins.
Potential risks associated with the transition from demonstration to commercial operations, including the need for timely execution and customer commitments.
Customers are showing increased urgency to secure contracts ahead of the Russian import ban, with a focus on prebuying.
Centrus is experiencing a shift in buyer behavior, with utilities more inclined to engage due to improved financial stability and reduced risk.
Discussions around pricing structures for offtake agreements remain confidential, but prepayment commitments are seen as beneficial for funding.
The company is actively working on cost savings and lead time reductions through partnerships and internal efficiencies, particularly with Palantir.
The timeline for commercial production at Piketon is still targeted for 2029, with potential for earlier advancements depending on operational progress. Overall, Centrus Energy demonstrated solid financial performance and strategic advancements in Q2 2026, while also facing challenges related to cost management and market dynamics. The company remains optimistic about future growth opportunities in the nuclear fuel sector.
SOURCE: Q2 2026 EARNINGS CALL TRANSCRIPT